Reveals improved chemosensitivity and radiosensitivity in cancer treatment via gene suppression, indicating potential benefits for affected individuals.
Panels, compositions, and methods for treating cancer in a subject in need thereof are disclosed involving one or more genes the suppression of which renders the cancer chemosensitive and/or radiosensitive.
No takes yet. Share an insight, caveat, or question.
Khodarev et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: